Journal of travel medicine

• Latest
• Best
• Search…

• J Travel Med · May 2022

  Immune responses against different variants of SARS-CoV-2 including omicron following six months of administration of heterologous prime-boost COVID-19 vaccine.

  no abstract available

  expand abstract… or not…

• J Travel Med · May 2022

  Multiple small pneumatoceles as a complication of a SARS-CoV-2 infection in a child from Myanmar.

  no abstract available

  read more… or not…

• J Travel Med · May 2022

  Real world experience on cruise ships in the Canary Islands highlight that safe travel is possible.

  no abstract available

  expand abstract… or not…

• J Travel Med · May 2022

  Erratum to: How does China keep COVID-19 outside its border? First-hand experience of medical staff at an international airport in China.

  no abstract available

  explore further… or not…

• J Travel Med · May 2022

  Assessment of geographic access to monoclonal antibodies in the United States.

  Using spatial modeling techniques, we highlight disparities in access to monoclonal antibodies (mAbs) used to treat COVID-19 patients. Fifteen million individuals in the United States must travel over 30 min to access mAbs. Areas with lower COVID-19 vaccination rates have worse access to essential COVID-19 therapeutics.

  keep going… or not…